atasehir escort bostanci escort erenkoy escort goztepe escort kadikoy Escort kartal Escort maltepe Escort suadiye Escort uskudar Escort umraniye Escort kartal escort bostanci escort atasehir escort kadikoy escort kurtkoy escort tuzla escort erenkoy escort beykoz escort umraniye escort pendik escort kadikoy escort maltepe escort antalya escort konya escort

Market Research Reports and Industry Reports

Medical Affairs Reputations (US) [Growth Hormone Deficiency]

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS

Don’t let good ratings fool you. Your medical affairs teams may still be letting doctors down

Our latest survey shows that while medical affairs teams for growth hormone brands in the EU5 countries (France, Germany, Italy, Spain, and the United Kingdom) are doing a passable job, they may be letting doctors down in other ways. From not valuing doctors’ time enough to not delivering enough of the information doctors really want, there are plenty of ways teams can, and should, improve.

Find out what your team can do to build better relationships with doctors, and get a leg up on the competition, in Medical Affairs Reputations: GHD (EU5).

Comparing 7 major growth hormone brands from Eli Lilly, Ipsen, Ferring, Merck Group, Novo Nordisk, Pfizer, and Sandoz, this report reveals:

What doctors really want from medical affairs teams
How doctors rate your team overall, and on specific medical affairs services.
Which medical affairs services are most important, and what you can do to improve them.

That’s actionable information you can use to turn your team into one that doctors rely on.

Interested in the European market? Click here to see the EU5 Edition.

Top Takeaways

Secret formula for success: The second-place team is holding onto its position despite having one of the lowest performance and satisfaction scores on most medical affairs services.
Two-tier market: Rated for overall quality of interactions, the top 3 teams are within less than 3 points of one another, while their closest rival is a full 6 points behind.
Shared blind spot: Need-gap analysis shows that nearly every team needs to do a better job of providing a specific kind of information. What is it, and which team is already delivering?
Need for practical information: Both the ways doctors use teams and the services they deem important reflect a need for information they can use to make better clinical decisions.
Welcome visitors: Teams tend to be contacting doctors about as often as doctors want to see them. Learn out whether your team is over- or under communicating.
Get to the point: Some respondents say that teams need to be better about respecting doctors’ time. See just how widespread a problem this is, and what other areas teams need to improve.

Insight into Medical Affairs Teams for These Growth Hormone Brands

Genotropin (somatropin; Pfizer)
Humatrope (somatropin; Eli Lilly)
Norditropin (somatropin; Novo Nordisk)
NutropinAq (somatropin; Ipsen)
Omnitrope (somatropin; Sandoz)
Saizen (somatropin; Merck Group)
Zomacton (somatropin; Ferring)

An Expert-designed Competitive View of Your Medical Affairs Team

Developed with the help of medical affairs specialists, this report gives you an in-depth comparison of 7 medical affairs teams—answering important questions like:

What do physicians need?

How, and how often are they using your medical affairs team?
What services do they consider most important?
How often should you contact them? What channels are best?

Does your medical affairs team deliver?

How memorable are your team’s interactions with doctors?
How do doctors rank your team for performance and satisfaction in 12 key areas?
How does your team compare to the competition—in each area, and overall?

What needs improvement?

Are you delivering the services that are most important to doctors?
Where do you need to improve?
How can your team enhance its services?

Based on Interviews with Practicing Doctors

We surveyed 100 US-based adult and paediatric endocrinologists, chosen from the largest community of validated physicians in the world.

All respondents:

Have been practicing for between 3 and 35 years
See at least 5 patients with growth hormone deficiency in a typical month
Devote at least 50% of their time to direct patient care
Have interacted with at least one listed product’s medical affairs team in the past 6 months.

1. Objectives, Survey Methodology and Sampling, Products Included in the Survey, Executive Summary
2. Current Status of Interactions with Different Medical Affairs Teams
3. Interactions in the past 6 months with Medical Affairs teams for each product
4. Current frequency of interactions with medical affair teams for each product
5. Competitive Evaluation of Medical Affairs Teams Performance on Various Attributes
6. Evaluation of overall quality of interactions with Medical Affairs teams for each product
7. Attribute importance of Medical Affairs teams roles to physicians’ practice
8. EdgeMap analysis – Competitive evaluation on Medical Affairs teams performance on attributes
9. Competitive evaluation of physicians satisfaction of interaction with Medical Affairs teams
10. Need-Gap analysis by product
11. Preferred Interaction Media, Frequency, and Suggestions for Improvement
12. Preferred interaction media and frequency, and suggestions for improvement
13. Appendix


Global Medical Staplers Detailed Analysis Report 2017-2022

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it

USD 3250View Report

Global Medical Staplers Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

The global Medical Staplers market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR

USD 2380View Report

Medical Affairs Reputations (EU5) [Growth Hormone Deficiency]

Dont let good ratings fool you. Your medical affairs teams may still be letting doctors downOur latest survey shows that while medical affairs teams for growth hormone brands in the

USD 6175View Report

Medical Affairs Reputations (EU5) [CLL]

How well does your CLL medical affairs team performance compare with the restIs moderately satisfied good enough According to this latest survey of 150 medical oncologists and haematologists across the

USD 6175View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


+91 9987 2952 42

CHOOSE FORMAT

  • PDF    USD 6175
  • Enterprise Wide Licence    USD 9275
$ 6175

Reports Details

Published Date : Aug 2017
Country :Global
Category :Healthcare
Publisher :FirstWord Dossier
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube